Doctor profile · Federal record

Dr. William Jawien, MD

Hematology & Oncology Physician (CMS: Medical Oncology) · Fresno, CA

  • NPI 1417904020
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 35 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
7130 N Millbrook Ave
Fresno, CA 937203347
(559) 326-1222
fax (559) 326-1225
Additional location
1125 E Spruce Ave Ste 103
Fresno, CA 937203387
(559) 878-4510
fax (559) 878-4515
Mailing address
Po Box 25100
Fresno, CA 937295100

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
October 9, 2025
Year of graduation
1991 — 35 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #G74904

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1417904020. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
298,823
Distinct HCPCS
10
Medicare allowed
$4,035,750
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 78,000 75 $1
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 61,200 66 $3
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram 32,760 15 $1
J9299 Injection, nivolumab, 1 mg 31,720 29 $30
J0185 Injection, aprepitant, 1 mg 11,180 33 $2
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 9,000 74 $0
J9271 Injection, pembrolizumab, 1 mg 8,600 15 $54
J1449 Injection, eflapegrastim-xnst, 0.1 mg 8,052 26 $32
J0897 Injection, denosumab, 1 mg 7,680 31 $23
J1930 Injection, lanreotide, 1 mg 6,360 11 $56

In context: peer comparison

Among 8 peers in this city , average services per provider: 4,484. This provider delivers 67× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,316
Transactions
89
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 11 $243.31
Celgene Corporation 19 $239.23
Daiichi Sankyo Inc. 9 $207.91
GlaxoSmithKline, LLC. 11 $189.21
ABBVIE INC. 8 $162.70
Exelixis Inc. 6 $143.00
Lilly USA, LLC 3 $106.02
Ipsen Biopharmaceuticals, Inc 3 $100.22
Novartis Pharmaceuticals Corporation 4 $83.57
PFIZER INC. 3 $76.90
SOBI, INC 2 $64.89
Stemline Therapeutics Inc. 2 $63.04
Gilead Sciences, Inc. 3 $62.57
E.R. Squibb & Sons, L.L.C. 3 $58.52
Regeneron Healthcare Solutions, Inc. 2 $54.80

By nature of payment

Food and Beverage
$2,262
Education
$54

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
825
Patients
160
Total drug cost
$2,074,622
Drug Type Claims Patients Total cost
Anastrozole Generic 159 28 $5,254
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 87 28 $2,560
Ondansetron Odt (Ondansetron) Brand 75 34 $1,571
Warfarin Sodium Generic 64 0 $1,196
Levothyroxine Sodium Generic 60 18 $621
Dexamethasone Generic 51 15 $696
Prochlorperazine Maleate Generic 47 26 $1,094
Eliquis (Apixaban) Brand 46 11 $34,870
Ibrance (Palbociclib) Brand 38 0 $604,942
Revlimid (Lenalidomide) Brand 37 0 $728,573

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. William Jawien's medical specialty?
Dr. William Jawien practices Hematology & Oncology Physician in Fresno, CA.
Where does Dr. William Jawien practice?
Dr. William Jawien practices at 7130 N Millbrook Ave, Fresno, CA 937203347. Office phone: 5593261222.
What is Dr. William Jawien's NPI?
Dr. William Jawien's National Provider Identifier (NPI) is 1417904020, issued by NPPES.
Does Dr. William Jawien accept Medicare assignment?
Yes. Dr. William Jawien accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. William Jawien commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram (HCPCS Q5125). Source: CMS Medicare Physician & Other Practitioners file.